Services
Drug Discovery
Toxicity Screening
Founded in 1995, JOINN Laboratories (stock codes: 603127.SH / 6127.HK) is a leading global Contract Research Organization (CRO) with operations in major cities across China - including Beijing, Suzhou, and Guangzhou, as well as in the United States, with facilities in San Francisco and Boston. JOINN is dedicated to accelerating the research and development of innovative therapies by delivering high-quality, globally aligned services. Our qualifications include CNAS/ILAC accreditation, multi-country GLP compliance (China, the United States, the OECD, Japan, and South Korea), and AAALAC accreditation, ensuring the highest international standards of quality and reliability.
Our laboratory is conveniently located in the San Francisco Bay area and features nearly 60,000 square feet of dedicated rodent vivarium space for mouse and rat models alongside advanced cell culture laboratory with robust in vitro capabilities, supporting a board range of preclinical research services.
Toxicity Screening
JOINN Laboratories is attending EUROTOX 2026 in Vienna from September 13–16. Meet our expert team at Booth #35 at Austria Center Vienna. We welcome face-to-face discussions on GLP non-clinical safety assessment, NAMs and global drug development strategies. Drop by to explore collaboration opportunities. Reach us via info@joinnlaboratories.com.
July 22–24, 2026 will witness the grand opening of the inaugural China Pharmaceutical Innovation Conference (CPIC 2026) at the National Exhibition and Convention Center (Shanghai). Benchmarked against
In May 2026, JOINN (Suzhou) completed an on-site audit conducted by the U.S. Food and Drug Administration (FDA). The quality management system fully satisfies FDA GLP requirements, earning a successfu